August 22, 2014 11:42 PM ET

Pharmaceuticals

Company Overview of Alaven Pharmaceutical LLC

Company Overview

As of October 4, 2010, Alaven Pharmaceutical LLC was acquired by Meda Pharmaceuticals, Inc. Alaven Pharmaceutical LLC, a specialty pharmaceutical company, develops and markets prescription and non-prescription products that treat women’s health, gastroenterological, and anemia conditions in the United States. The company's products for Gastroenterology are BiferaRx, Calafol Rx, COLYTE, Cortifoam, Dipentum, Levsin, Levbid, NuLev, Proctofoam NS, Proctofoam HC, Proctocream HC ,Reglan (metoclopramide tablets, USP), ROWASA, sfROWASA, TriLyte. Additionally, the company provides Anadrol-50 and Folpace Rx for anemia and feraRx, Calafol Rx, Epifoam, PreferaOB, PreferaOB + DHA, PreferaOB One, and Prim...

200 North Cobb Parkway

Building 400

Suite 428

Marietta, GA 30062

United States

Founded in 2003

Phone:

678-589-7000

Fax:

678-589-0500

Key Executives for Alaven Pharmaceutical LLC

Alaven Pharmaceutical LLC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
EPIC Nutrition, Inc. United States
G & W Laboratories, Inc. United States
BattelleCRO, Inc. United States
Knopp Biosciences LLC United States
CreoSalus, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alaven Pharmaceutical LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.